ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: DCE Board Nixes NIH Intramural Postdoctural Program Magazines Rapped For Cigarette Ads

July 13, 1984

Heidelberger Wins $100,000 Award

September 17, 1982

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

ASSIST Smoking Intervention gets Under Way In 1991

December 1, 1989

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006